Company Summary - Futura Medical PLC (LSE:FUM)
99.50p
0.00p
FTSE AIM All Share Pharmaceuticals & BiotechnologyMarket cap: £73.345m
NEW Explore our new and improved report for Futura Medical PLC >>
Gain access to various premium features such as detailed information on financial reports, broker forecasts, directors and shareholders information.
Summary
Research and development of medical devices and pharmaceutical drugs and their commercial exploitation
| Financials - Interim (27/9/2011) | ||
|---|---|---|
| Turnover | £m | 0.12 |
| Pre-tax Profit | £m | -0.7 |
| EPS | p | -0.85 |
| DPS | p | 0.00 |
| Director | Board Role |
|---|---|
| John Clarke | Chairman |
| James Barder | Chief Executive |
| Derek Martin | Finance Director & Company Sec |
Products Brands & Subsidiaries
Products & Brands
CSD500; DermaSys; Durex; MED2002; PET500; RAD100; TPR100; TPR100 Rx
Subsidiaries
There are no subsidiaries for this company.
Broker Sentiment (1 brokers)
Strong SellStrong Buy
| Heading | Date |
|---|---|
| Notification of major interest in sh... | 09/02/2012 |
| Total Voting Rights | 31/01/2012 |
| Directors' Dealings | 11/01/2012 |